Recent Findings in the Regulation of Programmed Death Ligand 1 ExpressionXiangfeng Shen, Zhi‐Xiang Xu|Frontiers in Immunology|2019Cited by 132
Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancerXiangfeng Shen, Zhixiang Xu, Guolong Liu et al.|Life Sciences|2020Cited by 34